Yahoo
NasdaqGM - Nasdaq Real Time Price USD

National Healthcare Properties, Inc. (NHP)

15.08 +0.12 (+0.80%)
At close: October 30 at 4:00:00 PM EDT
15.08 0.00 (0.00%)
After hours: October 30 at 4:00:02 PM EDT
Chart Range Bar
Loading chart for NHP
  • Previous Close 14.96
  • Open 14.85
  • Bid 11.47 x 200
  • Ask 19.95 x 200
  • Day's Range 14.63 - 15.16
  • 52 Week Range 11.25 - 17.46
  • Volume 1,163,270
  • Avg. Volume 876,998
  • Market Cap (intraday) 1.099B
  • Beta (5Y Monthly) 462.08
  • PE Ratio (TTM) --
  • EPS (TTM) -1.84
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield 0.30 (2.01%)
  • 1y Target Est 19.57
  • Zacks Rating Neutral

National Healthcare Properties, Inc. is a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States. National Healthcare Properties, Inc. was incorporated in 2012 in Maryland, USA.

www.nhpreit.com

31

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NHP
30.45%
S&P 500 (^GSPC)
10.73%

1-Year Return

NHP
30.45%
S&P 500 (^GSPC)
11.11%

3-Year Return

NHP
30.45%
S&P 500 (^GSPC)
81.91%

5-Year Return

NHP
30.45%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 87.53M
Earnings -8.14M
Profit Margin -9.30%

Q4

FY20

Q2

FY26

0
20M
40M
60M
80M
-8.0%
-6.0%
-4.0%
-2.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

17.00
19.57 Average
15.08 Current
24.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/19/2026
Analyst Wells Fargo
Rating Action Maintains
Rating Overweight
Price Action Lowers
Price Target 19 -> 18

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -13.04%

  • Return on Assets (ttm)

    1.19%

  • Return on Equity (ttm)

    -5.26%

  • Revenue (ttm)

    344.32M

  • Net Income Avi to Common (ttm)

    -57.6M

  • Diluted EPS (ttm)

    -1.84

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    248.06M

  • Total Debt/Equity (mrq)

    81.02%

  • Levered Free Cash Flow (ttm)

    46.83M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: